OPK Latest News

Analysts Set OPKO Health, Inc. (NASDAQ:OPK) Target Price at $2.03

defenseworld.net — Mar 20, 2026

OPKO Health, Inc. (NASDAQ: OPK - Get Free Report) has received a consensus rating of "Hold" from the seven brokerages that are currently covering the

Here's Why You Should Hold OPK Stock in Your Portfolio for Now

zacks.com — Mar 19, 2026

OPK rides on RAYALDEE strength and partnerships, but revenue decline, losses, and reliance on a single drug cloud its near-term outlook.

Critical Analysis: OPKO Health (NASDAQ:OPK) vs. Hypertension Diagnostics (OTCMKTS:HDII)

defenseworld.net — Mar 16, 2026

OPKO Health (NASDAQ: OPK - Get Free Report) and Hypertension Diagnostics (OTCMKTS:HDII - Get Free Report) are both medical companies, but which is the

OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts

zacks.com — Feb 27, 2026

OPKO Health beats Q4 earnings and revenue estimates, but sales decline and gross margin narrows.

OPKO Health to Participate in the Jefferies Biotech on the Beach Summit

globenewswire.com — Feb 27, 2026

MIAMI, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc.